Displaying 1-20 of 22 results for

Continuing ASTHO’s Legislative Prospectus series—which highlights the top 10 public health policy issues for 2022—we are focusing this week on mental and behavioral health as well as supporting the public health workforce.

Learn how state and territorial legislatures can bolster or restrict public health legal authority, with examples from early COVID-19 as well as 2024.

Each year, ASTHO notes the top public health policy issues to watch in the upcoming year. ASTHO has published a prospectus on several issues, with more coming later this month. ASTHO kicked off its top 10 public health state policy issues ...

Evidence suggests that access to healthy, safe, and affordable housing is connected to preventing suicide and overdose, with state and federal programs supporting access to housing for people with low incomes, substance use disorders, ...

In an effort to help meet demand, some states and territories have joined interjurisdictional licensing compacts that allow a mental healthcare provider licensed in one state to provide care in another state—without needing to gain ...

As leaders of their state agency, state and territorial health officials can be named parties in lawsuits alleging that an action taken by a public health agency was unlawful. These officials are typically sued in their “official ...

Learn about state and federal efforts to bolster the behavioral health workforce in response to the growing demand for behavioral health services.

ASTHO's 2024 Legislative Session Update: Part Two Beth Giambrone, Maggie Davis, Christina Severin ASTHO's Public Health Legislative Update on Tobacco, Mental Health, Environmental Health, Workforce, and Containing Infectious ...

PrEP is a powerful tool to reduce new HIV infections; expanding access to PrEP is a priority within the federal Ending the HIV Epidemic in the U.S. initiative. One way to increase access to PrEP is by allowing pharmacists to prescribe and ...

Explore how states are enacting legislation to help justice-involved people avoid overdose illness and death and foster a smooth transition after release.

The COVID-19 pandemic has impacted both the physical and mental health well-being of youth. Disruptions in both their home and school life have put youth at risk for poor mental health outcomes that include increased anxiety, depression, ...

May is Mental Health Awareness Month and the importance of continued mental health promotion and suicide prevention efforts during the COVID-19 pandemic. As we address the physical effects of COVID-19 through social distancing, mask ...

This episode explores the rise of suicide rates across the United States and the need for a comprehensive public health approach to suicide prevention. This discussion features a federal overview of the current landscape, Colorado’s ...

The COVID-19 pandemic has further amplified the need for strong tobacco prevention and cessation policies. Research indicates that tobacco use is associated with increased rate of COVID-19 disease progression and increased likelihood of ...

A mid-session legislative update on five of ASTHO's top 10 public health state policy issues to watch in 2023: tobacco, HIV, mental health, PFAS, and opioids.

ASTHO Legislative Prospectus | Prevention 2025 state legislative action on infectious disease control and prevention.

ASTHO Legislative Prospectus | Previewing 2025 state legislative actions on substance misuse and overdose prevention.

State and local jurisdictions are developing Ending the HOV Epidemic plans. The EHE initiative has largely focused on four key strategies: Diagnose, Treat, Prevent, and Respond to potential outbreaks. The EHE initiative set a goal to ...

States and municipalities are adopting tobacco retailer licensing (TRL) policies to control tobacco prevalence and impact. Learn more about TRL programs.

How the Emergence of Xylazine Impacts Overdose Prevention Policy overdose prevention policy, overdose crisis, fatal overdoses, emergence of xylazine, illicit drug supply, toxicological testing, withdrawal symptoms, xylazine test strips, ...